FDA Ruling on Statin Therapy

Published Online: Wednesday, December 19, 2012
Follow Pharmacy_Times:
In this video, David Dichek, MD, of the University of Washington Medical Center, discusses an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins. He also discusses how to address concerns that patients may have about taking statins in light of the waning.

Related Articles
A collaborative, pharmacist-led intervention targeted at health care professionals improves statin prescribing and lowers the risk of atherosclerotic events in patients with cardiovascular disease.
With proper treatment, individuals with atrial fibrillation can live normal and active lives.
Scientists from the Diabetes Research Centre at the University of Leicester have identified a link between low blood glucose levels and adverse cardiovascular events in patients with diabetes.
New research posits that cocaine use quadruples the risk of sudden cardiovascular death among individuals aged 19 to 49 years.
Latest Issues
$auto_registration$